Transcat, Inc. (NASDAQ:TRNS) CEO Sells $1,621,200.00 in Stock

Transcat, Inc. (NASDAQ:TRNS) CEO Lee D. Rudow sold 12,000 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $135.10, for a total transaction of $1,621,200.00. Following the sale, the chief executive officer now owns 91,692 shares of the company’s stock, valued at approximately $12,387,589.20. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Transcat Trading Up 0.0 %

Shares of NASDAQ TRNS traded up $0.04 during trading on Friday, hitting $134.51. 34,111 shares of the company were exchanged, compared to its average volume of 45,595. Transcat, Inc. has a 12-month low of $81.26 and a 12-month high of $147.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.81 and a current ratio of 3.37. The company has a fifty day moving average price of $114.10 and a 200-day moving average price of $106.47. The firm has a market capitalization of $1.19 billion, a PE ratio of 84.60 and a beta of 0.61.

Analyst Ratings Changes

Several equities analysts have recently weighed in on TRNS shares. Northland Capmk lowered shares of Transcat from a “strong-buy” rating to a “hold” rating in a report on Wednesday. TheStreet raised shares of Transcat from a “c+” rating to a “b” rating in a research report on Wednesday, January 31st. Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday. HC Wainwright lifted their price target on shares of Transcat from $124.00 to $156.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Oppenheimer upped their price target on shares of Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research note on Wednesday. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $142.67.

Hedge Funds Weigh In On Transcat

Hedge funds and other institutional investors have recently bought and sold shares of the company. Wasatch Advisors LP raised its position in shares of Transcat by 13.3% in the 4th quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company’s stock valued at $76,651,000 after purchasing an additional 82,458 shares in the last quarter. Broadcrest Asset Management LLC increased its position in Transcat by 17.6% in the 4th quarter. Broadcrest Asset Management LLC now owns 400,000 shares of the scientific and technical instruments company’s stock worth $43,732,000 after purchasing an additional 60,000 shares during the last quarter. Comerica Bank acquired a new position in shares of Transcat during the 3rd quarter valued at about $5,221,000. Vanguard Group Inc. lifted its position in shares of Transcat by 13.3% in the 3rd quarter. Vanguard Group Inc. now owns 425,378 shares of the scientific and technical instruments company’s stock worth $41,674,000 after acquiring an additional 49,828 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in Transcat by 196.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 59,482 shares of the scientific and technical instruments company’s stock valued at $5,827,000 after purchasing an additional 39,432 shares during the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.